phase readout
saveNCT07220252: Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: TG Therapeutics, Inc.. Phase: PHASE2. Conditions: Relapsing Multiple Sclerosis
view source ↗
comments(0)
5-min edit window · permanent after that